1: Yang S, Hu B, Wang Z, Zhang C, Jiao H, Mao Z, Wei L, Jia J, Zhao J. Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1-Drp1 pathway. Cell Death Discov. 2020 Oct 12;6:102. doi: 10.1038/s41420-020-00338-3. PMID: 33083022; PMCID: PMC7548964.
2: Aso E, Palomer E, Juvés S, Maldonado R, Muñoz FJ, Ferrer I. CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AβPP/PS1 mice. J Alzheimers Dis. 2012;30(2):439-59. doi: 10.3233/JAD-2012-111862. Erratum in: J Alzheimers Dis. 2012;31(3):679-80. PMID: 22451318.
3: Ma L, Jia J, Niu W, Jiang T, Zhai Q, Yang L, Bai F, Wang Q, Xiong L. Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions. Sci Rep. 2015 Jul 28;5:12440. doi: 10.1038/srep12440. PMID: 26215450; PMCID: PMC4516969.
4: Andres-Mach M, Zolkowska D, Barcicka-Klosowska B, Haratym-Maj A, Florek- Luszczki M, Luszczki JJ. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):301-9. doi: 10.1016/j.pnpbp.2012.07.001. Epub 2012 Jul 10. PMID: 22789660.
5: Andres-Mach M, Haratym-Maj A, Zagaja M, Rola R, Maj M, Chrościńska-Krawczyk M, Luszczki JJ. ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs. Brain Res. 2015 Oct 22;1624:86-94. doi: 10.1016/j.brainres.2015.07.028. Epub 2015 Jul 29. PMID: 26225920.
6: Kozan R, Ayyildiz M, Agar E. The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats. Epilepsia. 2009 Jul;50(7):1760-7. doi: 10.1111/j.1528-1167.2009.02098.x. Epub 2009 Apr 27. PMID: 19453709.
7: Zagaja M, Haratym-Maj A, Szewczyk A, Rola R, Maj M, Łuszczki JJ, Andres-Mach M. Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain. Neurosci Lett. 2019 Mar 23;696:79-86. doi: 10.1016/j.neulet.2018.12.016. Epub 2018 Dec 12. PMID: 30552944.
8: Asaadi S, Jahanbakhshi M, Lotfinia M, Naderi N. The Role of BK Channels in Antiseizure Action of the CB1 Receptor Agonist ACEA in Maximal Electroshock and Pentylenetetrazole Models of Seizure in Mice. Iran J Pharm Res. 2017 Spring;16(2):640-647. PMID: 28979317; PMCID: PMC5603872.
9: Rutkowska M, Fereniec-Gołebiewska L. Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration. Pharmazie. 2009 Sep;64(9):595-7. PMID: 19827302.
10: Rutkowska M, Gliniak H. The influence of ACEA--a selective cannabinoid CB1 receptor agonist on whole blood and platelet-poor plasma serotonin concentrations. Pharmazie. 2009 Sep;64(9):598-601. PMID: 19827303.
11: Rutkowska M, Jachimczuk O. Antidepressant--like properties of ACEA (arachidonyl-2-chloroethylamide), the selective agonist of CB1 receptors. Acta Pol Pharm. 2004 Mar-Apr;61(2):165-7. PMID: 15493300.
12: Haddad M. The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells. Pathophysiology. 2021 Oct 5;28(4):457-470. doi: 10.3390/pathophysiology28040029. PMID: 35366244; PMCID: PMC8830471.
13: Haddad M. The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells. J Inflamm Res. 2021 Aug 14;14:3959-3967. doi: 10.2147/JIR.S322247. PMID: 34421307; PMCID: PMC8373309.
14: Rutkowska M, Fereniec-Gołtbiewska L. ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB1 receptor agonist, protects against aspirin-induced gastric ulceration. Pharmazie. 2006 Apr;61(4):341-2. PMID: 16649551.
15: Schuster J, Ates M, Brune K, Gühring H. The cannabinoids R(-)-7-hydroxy- delta-6-tetra-hydrocannabinol-dimethylheptyl (HU-210), 2-O-arachidonoylglycerylether (HU-310) and arachidonyl-2-chloroethylamide (ACEA) increase isoflurane provoked sleep duration by activation of cannabinoids 1 (CB1)-receptors in mice. Neurosci Lett. 2002 Jul 5;326(3):196-200. doi: 10.1016/s0304-3940(02)00302-6. PMID: 12095655.
16: Rodriguez-Arias M, Navarrete F, Daza-Losada M, Navarro D, Aguilar MA, Berbel P, Miñarro J, Manzanares J. CB1 cannabinoid receptor-mediated aggressive behavior. Neuropharmacology. 2013 Dec;75:172-80. doi: 10.1016/j.neuropharm.2013.07.013. Epub 2013 Aug 2. PMID: 23916480.
17: Marquart S, Zerr P, Akhmetshina A, Palumbo K, Reich N, Tomcik M, Horn A, Dees C, Engel M, Zwerina J, Distler O, Schett G, Distler JH. Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis. Arthritis Rheum. 2010 Nov;62(11):3467-76. doi: 10.1002/art.27642. PMID: 20617520.
18: Wang S, Li B, Shen X, Duan H, Guo Z, Li X, Sun F. The cannabinoid receptor CB1 affects the proliferation and apoptosis of adenomyotic human uterine smooth muscle cells of the junctional zone: a mechanism study. Reprod Biol Endocrinol. 2021 Feb 2;19(1):16. doi: 10.1186/s12958-020-00690-0. PMID: 33531043; PMCID: PMC7852156.
19: Kenessey I, Bánki B, Márk A, Varga N, Tóvári J, Ladányi A, Rásó E, Tímár J. Revisiting CB1 receptor as drug target in human melanoma. Pathol Oncol Res. 2012 Oct;18(4):857-66. doi: 10.1007/s12253-012-9515-y. Epub 2012 Mar 24. PMID: 22447182.
20: Wang ZY, McDowell T, Wang P, Alvarez R, Gomez T, Bjorling DE. Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons. Neuroscience. 2014 Sep 26;277:679-89. doi: 10.1016/j.neuroscience.2014.07.041. Epub 2014 Aug 1. PMID: 25088915; PMCID: PMC4626020.